People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Other Technology, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Veylan, Inc. | — | Other Technology | Series A | $5.5M | $19.1M | 2025 |
| BioSymetrics, Inc. | — | Biotechnology | Series A | $4.9M | $105.6M | 2021 |
| AdTheorent Inc. | — | Other | Seed | $2.0M | $37.2M | 2013 |
Anthony Iacovone at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anthony Iacovone on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Scott Russo | 2 | 3 |
| Daniel Meehan | 1 | 3 |
| James Lawson | 1 | 2 |
| Enrique Nagle | 1 | 2 |
| Dirk Shaw | 1 | 1 |
| Gabriel Musso | 1 | 1 |
| Dustin Plummer | 1 | 1 |
| Dogan Aksoy | 1 | 1 |
| Mark Severini | 1 | 1 |
| Josh Walsh | 1 | 1 |
| Paul Severini | 1 | 1 |
| Saed Sayad | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.